 EMERYVILLE, Calif.--BUSINESS WIRE--NovaBay Pharmaceuticals NYSE American: NBY, a pharmaceutical company focusing on commercializing Avenova for the eye care market and CelleRx Clinical ResetTM for the beauty market, announces that management will hold one-on-one investor meetings at the Virtual 33rd Annual Roth Conference being held March 15-17, 2021. Investors interested in arranging a meeting with NovaBay management should contact their Roth Capital Partners sales representative or LHA I 